Stem cell jab aims to ease knee arthritis without surgery
NCT ID NCT07106229
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 23 times
Summary
This study tests whether a single injection of stem cells (MAG200) can reduce pain and improve daily function in people with knee osteoarthritis. About 573 adults aged 35–75 with moderate knee arthritis will receive either a low dose, high dose, or placebo shot. The goal is to see if the stem cells offer lasting relief compared to a dummy injection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRISTIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.